Scientists test new strategy to stop Leukemia's return
NCT ID NCT06664879
Summary
This study is testing a new, personalized approach to treat acute myeloid leukemia (AML) when it starts to come back. Doctors will use genetic information from a patient's cancer to choose specific drug combinations, aiming to attack the disease early based on tiny traces of leftover cancer cells. The main goals are to see if this tailored strategy is safe and can keep the cancer under control for a longer time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.